However, targeting TGF-β1 in CKD patients by TGF-β1 ablation did not yield exciting results in preventing/decreasing renal fibrosis, suggesting the complexity of fibrosis mediated by TGF-β1 and the necessity to identify potential antifibrotic factors and mechanisms4. Here, TGFB1 is linked to renal fibrosis.